GIPC1 and neoplasm: Histological analysis revealed increased protein levels of GIPC1 and TTC7B in tumors treated with GIPC1-LNPs, while the Ki67 proliferation index was significantly elevated in the control group, especially the combination therapy of GIPC1-LNPs and 5-FU notably inhibited tumor proliferation (Figure 8I-J).